Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.
Tsai
Feng-Chiao
FC
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, 7 Chung-Shan South Road, Taipei, Taiwan.
Hsieh
Song-Chou
SC
Chen
Ding-Shinn
DS
Sheu
Jin-Chuan
JC
Chen
Chien-Hung
CH
Chen
Ding-Shinn
DS
D004279:DNA, Viral / Q000097:blood; D017809:Fatal Outcome; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects*
D004279:DNA, Viral; D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine